Search
Home › Stocks › AZN › News
1 / 13 Next
Regulatory
15 Nov 07:00 - Qtrilmet approved in the EU for treatment of T2D
14 Nov 07:00 - FDA accepts regulatory submission for selumetinib
12 Nov 07:00 - Anifrolumab demonstrated superiority in TULIP 2
11 Nov 07:00 - Roxadustat pooled analyses: no increased CV risk
08 Nov 07:00 - Roxadustat significantly increased haemoglobin
06 Nov 14:10 - Calquence data to show improved progression-free
01 Nov 15:00 - Total Voting Rights
30 Oct 07:00 - AstraZeneca divests rights to Seroquel and
28 Oct 15:31 - Imfinzi and Imfinzi plus tremelimumab delayed
24 Oct 07:00 - AstraZeneca year-to-date and Q3 2019 results
21 Oct 07:00 - Farxiga approved in the US to reduce the risk of
17 Oct 07:00 - Trastuzumab deruxtecan granted FDA Priority Review
04 Oct 15:04 - Holding(s) in Company
04 Oct 15:00 - Holding(s) in Company
04 Oct 07:00 - Fasenra approved in the US for self-administration
03 Oct 16:00 - Director Declaration
01 Oct 15:00 - Total Voting Rights
01 Oct 07:05 - AstraZeneca divests rights for Losec to Cheplaphar
01 Oct 07:00 - Update on US regulatory review of PT010 in COPD
30 Sep 15:30 - Lynparza more than doubled the time without